136 related articles for article (PubMed ID: 38242126)
1. Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms.
Bejarano L; Kauzlaric A; Lamprou E; Lourenco J; Fournier N; Ballabio M; Colotti R; Maas R; Galland S; Massara M; Soukup K; Lilja J; Brouland JP; Hottinger AF; Daniel RT; Hegi ME; Joyce JA
Cancer Cell; 2024 Mar; 42(3):378-395.e10. PubMed ID: 38242126
[TBL] [Abstract][Full Text] [Related]
2. The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors.
Musca B; Russo MG; Tushe A; Magri S; Battaggia G; Pinton L; Bonaudo C; Della Puppa A; Mandruzzato S
Front Immunol; 2023; 14():1236824. PubMed ID: 37936683
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
Varešlija D; Priedigkeit N; Fagan A; Purcell S; Cosgrove N; O'Halloran PJ; Ward E; Cocchiglia S; Hartmaier R; Castro CA; Zhu L; Tseng GC; Lucas PC; Puhalla SL; Brufsky AM; Hamilton RL; Mathew A; Leone JP; Basudan A; Hudson L; Dwyer R; Das S; O'Connor DP; Buckley PG; Farrell M; Hill ADK; Oesterreich S; Lee AV; Young LS
J Natl Cancer Inst; 2019 Apr; 111(4):388-398. PubMed ID: 29961873
[TBL] [Abstract][Full Text] [Related]
4. Single-cell sequencing reveals the immune landscape of breast cancer patients with brain metastasis.
Zhou H; He X; Huang J; Zhong Y; Zhang L; Ao X; Zhao H; Hu S; Li H; Huang J; Huang H; Liang H
Thorac Cancer; 2024 Mar; 15(9):702-714. PubMed ID: 38316626
[TBL] [Abstract][Full Text] [Related]
5. RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis.
Sato R; Nakano T; Hosonaga M; Sampetrean O; Harigai R; Sasaki T; Koya I; Okano H; Kudoh J; Saya H; Arima Y
Biomed Res Int; 2017; 2017():8032910. PubMed ID: 28210624
[TBL] [Abstract][Full Text] [Related]
6. GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells.
Santana-Codina N; Marcé-Grau A; Muixí L; Nieva C; Marro M; Sebastián D; Muñoz JP; Zorzano A; Sierra A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395819
[TBL] [Abstract][Full Text] [Related]
7. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression.
Giannoudis A; Varešlija D; Sharma V; Zakaria R; Platt-Higgins A; Rudland PS; Jenkinson MD; Young LS; Palmieri C
ESMO Open; 2022 Dec; 7(6):100636. PubMed ID: 36423363
[TBL] [Abstract][Full Text] [Related]
9. To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3.
Kanchan RK; Doss D; Khan P; Nasser MW; Mahapatra S
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188783. PubMed ID: 36028149
[TBL] [Abstract][Full Text] [Related]
10. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
Li YQ; Sun FZ; Li CX; Mo HN; Zhou YT; Lv D; Zhai JT; Qian HL; Ma F
Mil Med Res; 2023 Jul; 10(1):34. PubMed ID: 37491281
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.
Grote S; Ureña-Bailén G; Chan KC; Baden C; Mezger M; Handgretinger R; Schleicher S
Cells; 2021 Apr; 10(5):. PubMed ID: 33925968
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature.
Bao R; Wang Y; Lai J; Zhu H; Zhao Y; Li S; Li N; Huang J; Yang Z; Wang F; Liu Z
Mol Pharm; 2019 Jan; 16(1):339-348. PubMed ID: 30452269
[TBL] [Abstract][Full Text] [Related]
13. Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Álvarez-Prado ÁF; Maas RR; Soukup K; Klemm F; Kornete M; Krebs FS; Zoete V; Berezowska S; Brouland JP; Hottinger AF; Daniel RT; Hegi ME; Joyce JA
Cell Rep Med; 2023 Jan; 4(1):100900. PubMed ID: 36652909
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
15. Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases.
Qian JM; Martin AM; Martin K; Hammoudeh L; Catalano PJ; Hodi FS; Cagney DN; Haas-Kogan DA; Schoenfeld JD; Aizer AA
Cancer; 2020 Dec; 126(24):5274-5282. PubMed ID: 32926760
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Blockade - How Does It Work in Brain Metastases?
Lorger M; Andreou T; Fife C; James F
Front Mol Neurosci; 2019; 12():282. PubMed ID: 31824260
[TBL] [Abstract][Full Text] [Related]
17. Cellular architecture of human brain metastases.
Gonzalez H; Mei W; Robles I; Hagerling C; Allen BM; Hauge Okholm TL; Nanjaraj A; Verbeek T; Kalavacherla S; van Gogh M; Georgiou S; Daras M; Phillips JJ; Spitzer MH; Roose JP; Werb Z
Cell; 2022 Feb; 185(4):729-745.e20. PubMed ID: 35063085
[TBL] [Abstract][Full Text] [Related]
18. The chromatin remodeling protein BRM regulates the transcription of tight junction proteins: Implication in breast cancer metastasis.
Yang Y; Liu L; Fang M; Bai H; Xu Y
Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):547-556. PubMed ID: 30946989
[TBL] [Abstract][Full Text] [Related]
19. Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8
Taggart D; Andreou T; Scott KJ; Williams J; Rippaus N; Brownlie RJ; Ilett EJ; Salmond RJ; Melcher A; Lorger M
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1540-E1549. PubMed ID: 29386395
[TBL] [Abstract][Full Text] [Related]
20. Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.
Shi H; Yang Y
Cancer Med; 2021 Jun; 10(11):3794-3807. PubMed ID: 33932112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]